Community-acquired Infections

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2019-06-19
EMA Withdrawn: Ketek (telithromycin) — Aventis Pharma S.A.
Telithromycin (Ketek) has been withdrawn from the European market by Aventis Pharma S.A. after regulatory assessment.